AzTrials
AzTrials

Learning Disorders, SpecificValidBMTINCT03919357

Using a New Calibrated Tool in Specific Language and Learning Disorders : the BMTi

An observational study of Learning Disorders, Specific and Developmental Disability, run by Centre Hospitalier Intercommunal Creteil at 16 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The group of experts at HAS has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications International Classification of Diseases (CIM) CIM 11 and Diagnostic and Statistical Manual of Mental Disorders (DSM) DSM 5. Read more about this study

Who is it for?
Ages 5 to 13 years
What is being tested?
BMT-i
How many people
229 participants
Where
16 sitesin 2 countries
Study dates
7 Mar 2019to 1 Apr 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children between 5 and 13 years old with a complex developmental and learning disorder

Who may be able to join

  • Child aged 5 to 13
  • Complex complaint affecting one of the different areas of development and learning
  • Affiliation to a social security scheme

Who cannot join

  • Diagnosis of intellectual development disorder of autism spectrum disorder and suspect or confirm
  • Refusal to participate

Trial locations and contacts

16 sites in 2 countries.

16 sites in 2 countries

France15 sites
  • Cabinet du Dr Vurpillat-Almanza

    Besançon

  • Cabinet du Dr Piollet

    Chamalières

  • Cabinet du Dr Gelbert

    Chambéry, 73000

  • CH Versailles - André Mignot

    Le Chesnay

  • Centre Médical Pédiatrique Flammarion

    Marseille

  • Hôpital Saint Eloi - Montpellier

    Montpellier

  • Cabinet du Dr Kochert

    Orléans, 45000

  • Centre Paris Santé Réussite

    Paris, 75020

  • Cabinet du Dr Cahn-Sellem

    Puteaux, 92800

  • CHU de Rouen

    Rouen

  • Cabinet du Dr Reynaud

    Saint-Denis

  • Cabinet du Dr Willig

    Toulouse

  • Cabinet du Dr Pineau

    Trélazé

  • Cabinet du Dr Lubelski

    Verrières-le-Buisson

  • Cabinet du Dr Werner

    Villeneuve-lès-Avignon

Other trials in France

Martinique1 site
  • Cabinet du Dr Dulorme

    Le Lamentin, 97129

Other trials in Martinique

About this study

Official title: Assessment of the Diagnostic Approach to Specific Language Disorders and Learning Using a New Calibrated Tool: the Modular Battery Tests Computerized (BMTi)

The group of experts at HAS has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications International Classification of Diseases (CIM) CIM 11 and Diagnostic and Statistical Manual of Mental Disorders (DSM) DSM 5. The referral to a second-level structure, a multidisciplinary structure in charge of carrying out the different cognitive assessments, requires a preliminary evaluation.

This orientation is based on a medical consultation, carried out by a doctor specialized in the field, with an exploration tool adapted to the different fields concerned.

Read more

The BMTi, a battery of third-generation tests (after the Rapid battery of evaluation of the cognitive functions (BREV) and then the Evaluation of cognitive functions and learning of the child (EDA)) will enable the doctor, from 2018, to carry out this orientation in a relevant way in response to children with a complaint about neurodevelopment and learning. .

The research project aims to validate this hypothesis, by comparing the diagnoses posed in a conventional way with the various multidisciplinary assessments, with the results of the transfer of all or part of the subtests of the BMTi by a doctor of second resort.

Read the detailed description

The group of experts at High Authority of Health (HAS) has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications CIM 11 and DSM 5. The referral to a second-level structure, a multidisciplinary structure in charge of carrying out the different cognitive assessments, requires a preliminary evaluation.

This orientation is based on a medical consultation, carried out by a doctor specialized in the field, with an exploration tool adapted to the different fields concerned.

The BMTi, a battery of third-generation tests (after the BREV and then the EDA) will enable the doctor, from 2018, to carry out this orientation in a relevant way in response to children with a complaint about neurodevelopment and learning. .

The research project aims to validate this hypothesis, by comparing the diagnoses posed in a conventional way with the various multidisciplinary assessments, with the results of the transfer of all or part of the subtests of the BMTi by a doctor of second resort.

This research project finds its place in a more global approach for a complete application of the recommendations of the group of experts of the High Authority of Health with:

  • the systematic evaluation of educational prevention strategies by intensive training in small groups of children with similar needs, in schools,
  • the evaluation of the role of the primary care physician in the prescription of the initial investigation report in the face of a simple reading, writing or numeracy disorder (research project with letter of intent filed in the framework of the call for tenders 38/5000 general direction of the offer of care (DGOS) PREPS 2018),
  • the current project to validate referral tools to second-level appraisals,
  • an evaluation project of the financing modalities filed under the regional health agency "Occitanie" in the framework of the call for tenders of article 51,
  • the introduction of training courses for the first and second-line tools for ambulatory doctors.
Being tested
BMT-i
Medical subject headings
Specific Learning Disorder, Developmental Disabilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BMT-iBehavioural

    Passing the BMT-i test

Study groups in NCT03919357
Study groupRoleWhat they receive
VerbalPassing of a specialized questionnaire on verbal disorders
Receives: Behavioral: BMT-i
Non-verbalPassing of a specialized questionnaire on non verbal disorders
Receives: Behavioral: BMT-i
AttentionPassing of a specialized questionnaire on attention disorders
Receives: Behavioral: BMT-i
Complaint about learningPassing of a specialized questionnaire on learning disorders
Receives: Behavioral: BMT-i

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensitivity of BMT-i (modular computerized test battery)

    Calculation of the sensitivity of the BMT-i compared to the reference balance sheets

    Measured: 3 months

  2. Specificity of BMT-i

    Calculation of the specificity of the BMT-i compared to the reference balance sheets

    Measured: 3 months

Secondary outcomes (4)
  1. Sensitivity and specificity of the BMT-i by type of complaint

    Calculation of the sensitivity and specificity of the BMT-i compared to the reference balance in each type of complaint (oral language, learning, graphics and attention)

    Measured: 3 months

  2. Kappa de Cohen test between BMTi assessments and the reference assessments

    Assessment of the concordance between the BMTi assessments and the baseline assessments

    Measured: 3 months

  3. Concordance between investigators evaluations and reviewers evaluations

    Evaluation of the concordance between the BMTi evaluations rated by the investigators and the reviewers

    Measured: 3 months

  4. Curves ROC (Receiver operating characteristic)

    Receiver operating characteristic (ROC) curves to validate selected BMT-i diagnostic thresholds

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2019
  2. Study start7 Mar 2019
  3. Primary completion1 Mar 2021
  4. Study completion1 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
229 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03919357
Sponsor's protocol ID
ValidBMTI2018
Other IDs
2018-A01870-55
Acronym
ValidBMTI
Status last verified
May 2021
First submitted
4 Apr 2019
Last updated
20 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Learning Disorders, Specific and Developmental Disability, run by Centre Hospitalier Intercommunal Creteil at 16 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 16 sites in France, Martinique. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensitivity of BMT-i (modular computerized test battery) (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in